EDAP TMS (EDAP) Met with U.S. FDA Over Prostate Cancer Trial Recommendations

December 16, 2009 9:34 AM EST Send to a Friend
EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, announced that the Company attended the Gastroenterology and Urology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login